Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy

Effectiveness of Hilotherapy for the Prevention of Oxaliplatin-induced Peripheral Neuropathy and Pain in the Treatment of Gastrointestinal Tumors: A Randomized Controlled Trial

Effectiveness of hilotherapy for the prevention of oxaliplatin-induced peripheral neuropathy and pain in the treatment of gastrointestinal tumors: A randomized controlled trial.

This study investigates whether constant cooling of the hands and feet using Hilotherm ChemoCare devices reduces the incidence of (severe) oxaliplatin-induced peripheral neuropathy and pain compared to standard care (i.e. no hand and foot cooling) in patients with gastrointestinal tumors.

Most important Eligibility Criteria:

Inclusion Criteria:

• 18 years or older
• Gastro-intestinal tumor, treated in UZ Leuven (University Hospitals of Leuven)
• Starting oxaliplatin-based treatment

Exclusion Criteria:

• Already grade 2 or higher peripheral neuropathy

For a more detailed list, see protocol.